Medtech Matters

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we conclude our conversation on the Netflix documentary, The Bleeding Edge. The documentary presents harsh criticism of the industry in terms of how devices are approved and what is done when problems arise. Throughout all three parts of this podcast series, we highlight a good number of points brought up in the documentary and analyze whether each is a fair criticism or not. Discussion topics in this third and final part include:  The dismissal of nine reviewers from the FDA who brought up concerns regarding certain processes and products.The lobbying power of the medtech and pharma sectors.The call for less innovation by several people in the documentary.A J&J executive admitting on film during a deposition that they were aware of issues with their mesh product.The observation that doctors seemed to require more evidence to abandon a product they were using then it took to initially have it approv